Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 22-05-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Kintor Pharmaceutical Limited Hong Kong Stock Exchange IPO | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May, Hong Kong, advised the sole sponsor, the joint global coordinators, the joint bookrunners and the underwriters on the Hong Kong and U.S. law aspects of the global offering and listing of Kintor Pharmaceutical Limited on the Main Board of the Hong Kong Stock Exchange, raising approximately HKD1.75 billion (approximately USD224 million) before exercise of the over-allotment option. Huatai Financial Holdings (Hong Kong) Limited (Huatai) acted as the sole sponsor, and Huatai, UBS AG Hong Kong Branch (UBS) and China International Capital Corporation Hong Kong Securities Limited (CICC) acted as the joint global coordinators.
|
||
| Financial Center: | Hong Kong | Value: | 100.01-500.00 |
| Advised Party: | Lead Managers | Law Firm | Slaughter and May |
| Issuer Jurisdiction- | China | Listing Jurisdiction- | Hong Kong |
| Classification: |
Initial Public Offerings Hong Kong Stock Exchange |
Lawyer | Benita Yu |
